Member Info for raharh

CF : "... antibody test that is transformational as that produces cash in a weeks time ... " @ 4:30

So monetised - tests around London. Is this purely because of their premises? You would think regional centres (Birmingham etc...) would be profitable.

But hey, I don't run the business CF does and I think he knows his eggs. I am still holding!

The raise is old news, but good news after listening to this.

GDR had a great RNS this morning, up 8% at the moment.

After 25% yesterday momentum still building and the only RNS news this week is about potential (i.e. a distribution platform with Medusa19) who wouldn't be standing up the eCommerce platform without confidence.

What will happen when the actual tests are ready and commercialised ..... cannot find any reason to sell any of this at the moment.

Placings are done for many reasons. Ultimately, we have a placing at 11p. CF has obviously been trying to dampen the share price for a week or so in his presentations so he has tried to keep the gap down. He will now be able to proceed on many more fronts with the additional funding. The Quotient machines are en route as tweeted by them in the week (or already here).

The target price touted has been 30p for some time, i think it will go higher but everyone has there positions and the share price is holding up because I dont think that has fundamentally changed. This isnt a huge retrace from recent highs for the issue of shares and there should be news on Tuesday or next week to move the SP up further.

I am in Avacta and people were 'dissappointed' that the BooHoo founders have the B2C eCommerce rights earlier in the week and that they have £2m invested claiming alsorts of 'mates rates'. Thats business and we are a realatively small cog but we grow as they grow and so I have no issue with the RNS today.

If it allows four income streams to move faster as a result rather than one then it is good for everyone.

Hold the faith!

Interesting - CF felt the next update would be 25th or 26th (likely to be 26th obv. as BH Monday) and also updating investments on the Thursday. He certainly is putting a lot of publicity out. There has to be an update on the Quotient machines imminently now they are shipped.

I think Roche and Abbot was already well known about. He mentioned that they were working through three other suppliers.

Coupled with what CF said last week and that Quotient tweeted about the dispatch of the machines to Open I have to think one of these three is Open and so hopefully a start of week RNS from CF will land confirming.

Thoughts?

*touting

Predicative text!

I am in both so neutral. But the market will see in Medusa19 a team that know how to deliver e-commerce to the customer. It does not matter what anyone thinks about BooHoo, they know there market and have built a fantastic business.

Omega are in great company I agree and people just want progress as they are wanting daily news which doesn’t always happen. Both omega and sng will drift without news.

There is room for a number of the businesses here and I am not touring any of them specifically as people need to decide where to put their hard earned cash. There is a lot of ‘my share is better than your share’ but I don’t see any need Odx and Avacta are both good prospects as are others. DYOR

Cyprus
CF mentioned it in his last interview - expecting one 25th / 26th - 25th bank holiday so i think there is a general assumption on Tuesday. We have had 3 RNSs 3 Mondays in a row. He is very communicative!

Denn - why do you focus on UK FOC tests (which they wont be - people will want to test themselves regularly - especially with vulnerable relatives).

Key word's : WORDLWIDE, BOOHOO (They know how to market and build distribution)

The fact everyone is getting on board with Avacta (Cytvia, Adeptrix, Medusa) and remember they are not just a Covid-19 play.

This is great news, but still holding ... more to come IMO! DYOR

Good Find and with CF basically signalling an RNS on Tuesday next week the momentum seems to be continuing. Thanks for all the research on here, I increased yesterday, just a modest increase by most investors terms but still enough to get me excited about the prospects. Going to be an interesting few weeks between Open Orphan and my other stock in Avacta.

Some of the debate on these boads is fruitless.

Ultimately there is a huge market.

Roche and Open Orphen (via Quotient) are lab based antibody tests - needed
Omega (and RTC) are developing POC home based instant result antibody tests - needed

POC antigen tests will be needed, lab based antigen tests will be needed, vaccines will be needed, treatment will be needed.

This is a global market with limited countries able to bring the innovation so there is plenty of room.

There is not one solution or one player in this market so why is everyone so partisan on these BBs. If this is not the share for you then move on, just because you invest here doesnt mean you cant invest elsewhere.

Let's not forget, Omega has Mologic partnership in the bag, Design Freeze expected in weeks (which will tick up the sp) and have just built a second facility in a week for production.

Out of the 'Covid' plays Omega seem to be less vocal than the likes of Avacta and Orph and that can make people nervous but it feels like the share has found a range of 45 - 55 until further news which I can only see being positive and that is the design freeze which they would not be saying 'weeks not months' if they were not confident and close.

Forget the daily movements and shut it down, when the RNS drops people will make investment decisions - some will regret it and some wont - some will sell and some wont - is that not what dealing is all about?

CF indicated that his was the second test in the broadcast.

This sounds promising.

https://www.bbc.co.uk/news/uk-52713127

All of this is quite difficult to navigate especially if you are new to investing (a lockdown newbie here) but it looks like the other test on the briefing is Quotient - which Open Orphan have exclusive rights to according Orph CEO in broadcast tonight.

https://twitter.com/Gravy_Stock/status/1261032096065376258

Still a lab test and just to declare as I know people seem to get sensitive about what board you post on I have more ODX than ORPH and I am also in Avacta - but if i have interpreted today right it is good for ORPH and the sky interview talking about the Oxford test is good for ODX.

Hopefully an imminent RNS's will get this moving now.

PS Not selling, POC test will be critical, but i believe you sign off with IMHO DYOR!

Legendgerry - great post and informative. I watched the press briefing tonight and could not decide if I was excited about ODX or OPEN - this should be great moving forward.

Do you think this means an RNS in the morning as it is now so public or will they wait for installation and orders?

Fairly new to investing so not sure if this would be classed as significant enough.

It's following the market and the Dow has opened 1% down. Probably got a little more to drop but the company is going nowhere with strong public sector contracts - they need to turn there services business more profitable but the software is the jewel in the crown IMO one to just hold throughout all the chaos but a great entry point around these levels

I know it is exhausting waiting for the next update and we all expected it this week, well the world doesn't revolve around this billboard. But this afternoon seems to have descended in to childish name calling and sarcasm. Is everyone bored?
Great company with great prospects and not just dependent on Boris and the RTC. Crack a beer and lets see what next week brings.

I would be careful - this is not a meteoric share IMO - I think this company has long term potential but it is a share that has had the price pumped twice in recent weeks (last spike was 15p) and this has a similar feel. It could retrace back to 6p, there is no real game changing news to support some of the spikes in this share. I think it has excellent links in the US and its treatments for cancer look to have major promise but i think it will take time.

This is just more good news - not a one trick pony and will be interesting to see how tomorrow goes on the back of this.

MerchantBanker - spot on - that's why this is the one share I have held through all the wild rises elsewhere. It is the manufacturer and has two major partnerships in place. It has built additional capacity in one week (why would you do that if you were not expecting the demand).

I am new to investing / trading (cannot decide what I am yet) and I have learnt painfully over the month how you can get easily mugged reading these boards and chasing the next big riser but ODX is different to the other players. It will be able to build what they invent and thats why I am in even if the wait for news is exhausting!

I feel your pain. I bought in at 2.06 and thought and saw it falling, i have been spiked before on HEMO and thought - oh no I have done it again. Tried to sell at 1.86 but it failed so luckily still in (at least i think so - we will see). Lockdown has got me interested but I need to get out to get away from these boards and the live prices!